NCT06732999

Brief Summary

The goal of this study is to examine if a digital behavior-based framework, utilizing the BHQ app, can effectively monitor social anxiety symptoms and evaluate the symptom-reducing impact of attentional training for adults (18-65) with social anxiety disorder (SAD), compared to traditional clinical questionnaires and self-reports. The main questions it aims to answer are:

  • Complete an initial clinical interview and self-report questionnaires.
  • Engage in a computer-based "free-viewing" task for baseline attention assessment using eye tracking.
  • Connect to the BHQ app for continuous monitoring throughout the study.
  • Undergo attentional training, GC-MRT.
  • Complete weekly SPIN assessments.
  • Undergo Final evaluation two weeks post-treatment including repeated clinical interviews, self-reports, and the computer-based task to assess changes in attention patterns and symptom reduction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 24, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

November 24, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 13, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
Last Updated

September 8, 2025

Status Verified

December 1, 2024

Enrollment Period

8 months

First QC Date

November 24, 2024

Last Update Submit

September 4, 2025

Conditions

Keywords

GC-MRTSocial Anxiety Disorder (SAD)Digital BehaviourSmartphoneSmartphone assesment

Outcome Measures

Primary Outcomes (1)

  • The Liebowitz Social Anxiety Scale (LSAS)

    Clinician-rated severity of social anxiety symptoms

    From Pre meeting measurements in week 0 to post training measurements in week 10

Secondary Outcomes (2)

  • Threat-related attention bias

    From Pre meeting measurements in week 0 to post training measurements in week 10

  • The Social Phobia Inventory (SPIN)

    From Pre meeting measurements in week 0 to post training measurements in week 10

Study Arms (1)

Starting GC-MRT training after randomized allocation of period of time after assesment

EXPERIMENTAL

Gaze-Contingent Music Reward Therapy (GC-MRT) is a treatment method for adults with social anxiety disorder found to be effective in reducing social anxiety in various RCTs. This method includes a computerized cognitive training to redirect threat-related attention patterns. Time period between Pre assessment and start of GC-MRT is randomly assigned (1 week/ 2 weeks/ 3 weeks) to create a multiple baseline design.

Behavioral: Gaze-Contingent Music Reward Therapy (GC-MRT

Interventions

Gaze-Contingent Music Reward Therapy (GC-MRT) is a treatment method for adults with social anxiety disorder found to be effective in reducing social anxiety in various RCTs. This method includes a computerized cognitive training to redirect threat-related attention patterns.

Starting GC-MRT training after randomized allocation of period of time after assesment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Normal or corrected vision, without color blindness.
  • A primary diagnosis of social anxiety disorder (based on clinician assessment (LSAS), a MINI interview, and an LSAS score above 50).
  • Age range of 18-65.
  • Ownership of a smartphone that supports the digital monitoring App.

You may not qualify if:

  • Prior experience with GC-MRT.
  • A current diagnosis of post-traumatic stress disorder (PTSD).
  • A current or past diagnosis of psychosis or bipolar disorder.
  • Neurological disorder (e.g., epilepsy, brain injury).
  • Severe suicidal ideation.
  • Substance or alcohol addiction.
  • Concurrent treatment (pharmacological or psychosocial).
  • Pregnancy.
  • Insufficient Hebrew proficiency (unable to complete a clinical interview and/or self-report symptoms and/or perform cognitive tasks).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel Aviv University

Tel Aviv, Israel

Location

Related Publications (1)

  • Arad G, Azriel O, Pine DS, Lazarov A, Sol O, Weiser M, Garber E, Bloch M, Bar-Haim Y. Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting List Control for Social Anxiety Disorder: A Randomized Clinical Trial. Am J Psychiatry. 2023 May 1;180(5):357-366. doi: 10.1176/appi.ajp.20220533. Epub 2023 Mar 22.

    PMID: 36945823BACKGROUND

MeSH Terms

Conditions

Phobia, Social

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Study Officials

  • Yair Bar-Haim, Professor

    School of Psychological Sciences and Sagol School of Neuroscience, Tel Aviv University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SEQUENTIAL
Model Details: Participants will be assigned to three groups with varying intervals between the pre-assessment and the start of treatment, following a multiple-baseline design (Group A - 1 week; Group B - 2 weeks; Group C - 3 weeks). All participants will receive the same treatment (GC-MRT).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 24, 2024

First Posted

December 13, 2024

Study Start

November 24, 2024

Primary Completion

July 30, 2025

Study Completion

July 30, 2025

Last Updated

September 8, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations